A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo
Clinical trial NCT05750823 · COMPLETED
Trial details
- NCT number
- NCT05750823
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-11
- Primary completion
- 2025-03-06
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.